Confidant
- 02 Mar 2007 10:50
Not professing skills in this area but attracted to company by its client list
Pfizer, Johnson&Johnson, Roche and Novartis all clients to name but a few
Company effectively reproduces human response to possible drugs, creams etc . Effectively builds a"virtual patient". Others do this but not sure they have the client list
Seems to get repeat business plus looks to be on c2x - 2.5x sales year just ended. IMHO too low for such a stock. Recent news in Feb all good and suggests on certain ventures they get some interest in new compunds developed
Listed above this price -- 85p --- this time last year. Results should be in next few weeks. Any thoughts?
goldfinger
- 02 Mar 2007 23:01
- 9 of 19
Still interested
Confidant
- 05 Mar 2007 15:33
- 11 of 19
What's that Soul --- the wife is holding the purse strings ???? ;-)
hewittalan6
- 05 Mar 2007 18:11
- 13 of 19
Clearence from a compliance department??
You'll get an audience with the pope quicker than that.
Confidant
- 12 Mar 2007 08:45
- 15 of 19
Sales warnings ---- profit warning
Apologies for starting thread -- effectively a whipping boy for the major pharmas
Price taker not maker
Apologies again
hewittalan6
- 12 Mar 2007 09:27
- 18 of 19
Don't beat yourself up over it!!!
You started the thread with integrity.
That is the important point. It is those that start them without integrity that should apologise.
Just glad I never got in, though I was watching it!! ;-)
Alan
Confidant
- 12 Mar 2007 11:55
- 19 of 19
thx for the comments. Will stay away from this now, as can't see good news or a profit for long time given they say an adjustment to business will be needed to cut costs